Prandin and Pregnancy
Although the drug did not cause problems in animal studies on Prandin and pregnancy, medications that affect blood sugar can increase the risk of birth defects, so the FDA has classified Prandin as a pregnancy Category C medication. This means that it may not be safe to take during pregnancy. However, if you are taking Prandin and pregnancy occurs, your healthcare provider will weigh the benefits and risks before making a recommendation.
Prandin® (repaglinide) may not be safe for women to take during pregnancy. This is based on animal studies that looked at the effects of the drug during pregnancy.
The U.S. Food and Drug Administration (FDA) uses a category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category C is given to medicines that have not been studied in pregnant humans but that caused harm to the fetus in animal studies. Also, medicines that have not been studied in pregnant women or animals are automatically given a pregnancy Category C rating.
Although Prandin did not cause any problems when given to pregnant animals, it was given a pregnancy Category C rating because it is known that medications that affect blood sugar levels can increase the risk of birth defects when taken by pregnant women. However, a pregnancy Category C medicine may be given to a pregnant woman if the healthcare provider believes that the benefits to the mother outweigh any possible risks to the unborn child.
If you are taking Prandin and pregnancy occurs, or if you are thinking about becoming pregnant while taking the drug, let your healthcare provider know. He or she will consider the benefits and the risks before making a recommendation for your particular situation.